Cell therapy for stroke and spinal cord injury in clinical trials
Stem Cells Translational Medicine · 2026
DOI: 10.1093/stcltm/szaf082 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Stem Cells Translational Medicine, 2026. Verfasst von Yiping Fan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Reproductive Medicine, KK Women's and Children's Hospital, 229899, Singapore. Hauptthemen laut MEDLINE: Spinal Cord Injuries, Stroke, Cell- and Tissue-Based Therapy. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 109 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Medical Research Council, Singapore.
Themen: Schlaganfall
Abstract (Originalsprache)
Brain injury describes a variety of injuries to the tissues and blood vessels in the head. It can be external such as in road accident or physical assaults or internal such as a stroke. Regardless, they are largely incurable with a long route to recovery with symptoms-relieving medications and rehabilitation. As such, many therapies were explored including cell therapy. However, not all were evidence based and in many instances banking of patients’ desperation, many treatments were done without any evidence from clinical trials. Here, we reviewed clinical trials on clinicaltrials.gov for stroke and spinal cord injury where there are cellular therapies transplanting neural, mesenchymal, and haemopoietic cells. We present and discuss 40 trials involving cell therapies for stroke and 32 for spinal cord injuries that are either completed or active. Although some trials began as long as 20 years ago and have shown encouraging improvements in various scale scores for both stroke and spinal cord injury, cell transplantation for brain injuries remains an evolving field that requires further research before it can be established as a standard treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Reproductive Medicine, KK Women's and Children's Hospital, 229899, Singapore.
- Experimental Fetal Medicine Group, Department of Obstetrics and Gynaecology, Yong Loo Lin School of Medicine, 117597, Singapore.
- Academic Clinical Program in Obstetrics and Gynaecology, Duke-NUS Medical School,169857, Singapore.
- Neuroscience Faculty, Boston University, Boston, MA 02118, United States.
- Neuroscience and Mental Health Faculty, Lee Kong Chian School of Medicine, Nanyang Technological University, 308232, Singapore.
ORCID-Profile: Yiping Fan
Förderung
- National Medical Research Council, Singapore
Zitieren
APA
Fan, Y., Wong, S. T., Goh, E. L. K., & Chan, J. K. Y. (2026). Cell therapy for stroke and spinal cord injury in clinical trials. Stem Cells Translational Medicine. https://doi.org/10.1093/stcltm/szaf082
Vancouver
Fan Y, Wong ST, Goh ELK, Chan JKY. Cell therapy for stroke and spinal cord injury in clinical trials. Stem Cells Translational Medicine. 2026. doi:10.1093/stcltm/szaf082
BibTeX
@article{Fan2026,
author = {Fan, Yiping and Wong, Si Tau and Goh, Eyleen L K and Chan, Jerry K Y},
title = {Cell therapy for stroke and spinal cord injury in clinical trials},
journal = {Stem Cells Translational Medicine},
year = {2026},
doi = {10.1093/stcltm/szaf082}
}
EUVIMED